Immix Biopharma Inc. (NASDAQ: IMMX) Stock Information | RedChip

Immix Biopharma Inc. (NASDAQ: IMMX) Listen to this Section


$1.90
+0.0050 ( +0.27% ) 78.2K

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

Market Data


Open


$1.90

Previous close


$1.89

Volume


78.2K

Market cap


$52.16M

Day range


$1.83 - $1.92

52 week range


$1.55 - $7.75

Insider Ownership Transactions

Total Amount Purchased: 130,800.00 | $ 247,866.00

Date Type Amount Purchased Purchaser
2024-05-14 Buy 4500.00 Morris Gabriel S
2024-05-14 Buy 4300.00 Rachman Ilya M
2023-12-12 Buy 25000.00 Hsu Jason
2023-09-18 Buy 25000.00 Hsu Jason
2023-09-15 Buy 10000.00 Ng Carey
2023-09-14 Buy 13000.00 Adams Helen C.
2023-09-12 Buy 10000.00 Hsu Jason
2023-09-11 Buy 20000.00 BUCHAN MELISSA JANE
2023-09-08 Buy 9000.00 Marquet Magda
2023-09-06 Buy 10000.00 Marquet Magda

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 May 20, 2024
8-k 8K-related 14 May 20, 2024
4 Insider transactions 1 May 20, 2024
4 Insider transactions 1 May 20, 2024
4 Insider transactions 1 May 20, 2024
4 Insider transactions 1 May 14, 2024
4 Insider transactions 1 May 14, 2024
10-q Quarterly Reports 63 May 09, 2024
ars Annual reports 1 Apr 30, 2024
def Proxies and info statements 1 Apr 29, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.